INTERIM REPORT 1 JANUARY - 31 MARCH 2012: BOTTOM PASSED IN THE SEMICONDUCTOR CYCLE, ORDERS INCREASING AGAIN
Comunicato Precedente
Comunicato Successivo
OKMETIC OYJ STOCK EXCHANGE RELEASE 27 APRIL 2012 AT 8.00 A.M.
INTERIM REPORT 1 JANUARY - 31 MARCH 2012: BOTTOM PASSED IN THE SEMICONDUCTOR CYCLE, ORDERS INCREASING AGAIN
Unless otherwise stated, figures in parenthesis refer to the corresponding period in the previous year.
JANUARY-MARCH IN BRIEF:
-
Net sales amounted to 18.9 (22.1) million euro, down 14.3%.
-
Operating profit was 1.5 (2.8) million euro corresponding to 8.1% of net sales.
-
Profit for the period was 0.7 (2.7) million euro.
-
Basic earnings per share was 0.04 (0.16) euro.
-
Net cash flow from operations amounted to -1.0 (-1.3) million euro.
PROJECTIONS FOR THE NEAR FUTURE
The customer industries are estimated to grow moderately in Okmetic's main product groups in 2012. The levelling of semiconductor industry's inventories, which started in mid-2011, seems to have ended in the end of the period under review, as anticipated. The orders of semiconductor wafers began to increase in March. This indicates that the downward trend of around three quarters has ended.
The development of sensor wafer demand is estimated to be somewhat more stable in 2012 than the demand for semiconductor wafers. The growth of sensor wafer demand seems to focus on the second half of the year, while the beginning of the year is still a time of lower demand.
Technology sales will focus on solar crystal sales, and be fairly even until the shipment contracts that are valid until the third quarter will be terminating. The solar cell industry's strongly lowered price level is likely to accelerate the consolidation in the industry. This development has no direct effects on Okmetic's technology business.
The company retains the existing guidance, according to which the net sales and operating profit for 2012 are estimated to exceed the level of 2011, although they remained under the level of the comparison period in the first quarter, as anticipated.
PRESIDENT KAI SEIKKU:
"The semiconductor market which took a downward turn in summer 2011 hit the rock bottom in January-February. The long-awaited turn for the better was evident in March, after which the order backlog has started to grow. As predicted, Okmetic's net sales and operating profit in the first quarter remained under the strong level of the comparison period. Thanks to the sales efforts the company's market share rose to a record level in the first quarter in the product groups important to the company, which partly softened the impact of the steep market drop on the company's operation.
The operating profit of the first quarter was lowered significantly due to a disturbance that took place in the production chain of a gas in the USA. The gas is used in the manufacture of epi-coated wafers. In practice, Okmetic's Allen production plant had to be idled for almost a month. The shipments of epi wafers during the shutdown were only a fraction of the order backlog, and the first quarter in the US-based subsidiary was in this respect unprofitable.
The delivery disturbance that burdened the entire industry in the US was caused by a fault in the process of the only gas supplier on the market. The fault has since been located and fixed. The company believes it can deliver majority of the lost orders during the rest of the year.
In the first quarter, the operating profit was also weakened by the less advantageous product mix compared to the previous quarter and to the corresponding quarter last year, some non-recurring expense items related to foreign subsidiaries, and the changes in the fair value of electricity derivatives as the price of electricity declined further. The capacity utilisation rate was deliberately maintained partly with products of lower margin.
Despite the several challenges, the operating profit (8.1%) in the first quarter nearly reached the minimum level of 10 percent which is the company's long-term objective. The factors behind the success are the business volume that has increased in recent years and the supply chain that is more flexible than before and continuously under development.
The clear decline in the profit for the period in relation to the comparison period was caused not only by lower operating profit but also by a difference of nearly one million euro in income tax entered as expenses. Along with the good profitability development in recent years, Okmetic managed to deduct the earlier confirmed losses from its result by the end of summer 2011. Similar to last year, the net cash flow of the period under review was weighed down by advance payments and working capital items. The cash flow is expected to improve in the end of the year, the same as last year.
The demand for semiconductor wafers has clearly picked up as of March, which predicts strong development starting from the second quarter. The demand for sensor wafers, on the contrary, will probably reach full speed a little later, that is, during the second half of the year. The demand for sensor wafers has been restrained by high inventory levels and the increasing focus of sensors on consumer electronics, exposed to economic fluctuations. In the period under review, technology sales consisted largely of solar crystal sales."
KEY FIGURES
|
1,000 euro |
1.1.- |
1.1.- |
1.1.- |
1.1.- |
|
|
|
|
|
|
|
Net sales |
18,902 |
22,055 |
83,186 |
80,907 |
|
Operating |
|
|
|
|
|
Operating |
|
|
|
|
|
% of net sales |
8.1 |
12.8 |
14.2 |
12.9 |
|
Profit for |
|
|
|
|
|
Basic earnings |
|
|
|
|
|
Net cash flow |
|
|
|
|
|
Net interest- |
|
|
|
|
|
Equity ratio, % |
79.2 |
78.9 |
78.9 |
76.6 |
|
Average number |
|
|
|
|
MARKETS
Customer industries sensor, semiconductor, and solar cell industries
Sensor industry
In 2012, the sale value of sensor industry is estimated to grow 11-15 percent compared to the sale value of 2011 (8.6-10.2 billion US dollars). One of the fastest growing sectors is MEMS products for consumer applications such as microphones and gyroscopes. In the next few years picoprojectors are estimated to be a significant growth area in consumer applications. (IHS iSuppli, IC Insights, Yole) Nowadays, silicon-on-insulator (SOI) technology is widely used in the manufacture of these next generation products, and the share of SOI technology is estimated to continue its growth. Okmetic is amongst the pioneering suppliers who provide products and services based on SOI technology to the sensor industry.
Semiconductor industry
The US dollar based sales of the semiconductor industry have started to recover during the first quarter of the year. The estimates for the sale development in 2012 have improved and they settle now at a level of 3-7 percent of annual growth. (IHS iSuppli, Gartner, IC Insights, VLSI Research)
The growth in demand that started in the first quarter of 2012 is expected to accelerate in the second half of the year (IDC). The demand for semiconductors is boosted by both strongly increasing applications, such as tablet computers, and the uplift of developing markets (Gartner).
In the long run, the growth rate of semiconductor demand is estimated to remain at a yearly level of 5-9 percent (IDC, IC Insights). The growth rate of discrete and power semiconductors is estimated to slightly exceed the semiconductor market average (IC Insights, IHS iSuppli, Yole).
Solar cell industry
The almost 10-year-long very strong 40-50 percent annual growth of new solar energy based (Photovoltaic) power plants is moderating. On average, annual growth of 20-30 percent is estimated for the near future. (IHS iSuppli) The use of solar energy for electricity production is expanding to more and more countries as the costs go down. Already over 20 countries are estimated to build more than 100MW of capacity during 2012. (IMS Research)
In the short run, the changes in feed-in tariffs in Germany and Italy create uncertainty in the market. Significant overproduction and structural change throughout the industry's supply chain are predicted to continue during 2012.
Silicon wafer market
According to the statistics published in February 2012 by SMG, the group of silicon wafer suppliers in SEMI, the surface area of wafer shipments in the whole silicon wafer industry in 2011 decreased by three percent compared to 2010 area shipments. The transfer of the market to bigger wafer sizes along with the technological development was stronger than average. Compared to the previous year, a growth of three percent is estimated for 2012.
Okmetic's central customer areas in the silicon wafer market
In line with its strategy, Okmetic seeks for special areas of the entire silicon wafer market that have greater growth rates than the market average and in which the company has special expertise. Okmetic supplies primarily 150mm and 200mm wafers. The sensor/MEMS industry is Okmetic's central growth area. The MEMS market grows as portable consumer products, automotive electronics, and industrial process control increase.
In the semiconductor market, Okmetic's growth areas include discrete and power semiconductors. The growth areas of these markets are i.a. components used in the production of renewable energy, increasing automotive electronics, portable consumer products, as well as different solutions related to power supply and efficiency improvement.
SALES
In January-March, Okmetic's net sales amounted to 18.9 (22.1) million euro. There was a decrease of 14.3 percent (growth 33.5%) for the comparison period mainly due to the prevailing market trend. Okmetic's market share grew in the product groups which are important to the company, and sales improved clearly towards the end of the first quarter because of the strengthened economic situation.
Sales per customer area
|
|
1.1.- |
1.1.- |
1.1.- |
1.1.- |
|
|
|
|
|
|
|
Sensors |
46% |
45% |
46% |
43% |
|
Semiconductors |
34% |
33% |
35% |
42% |
|
Technology |
20% |
22% |
19% |
15% |
In January-March, the value of sensor wafer shipments was 14.0 percent lower than in the corresponding period last year. Sensor wafer sales were weighed down by the customers' bloated inventory levels in the beginning of the year. The demand for sensor wafers is expected to pick up in the second half of the year.
The downward trend in the semiconductor industry saw a clear change at the end of the first quarter which contributed positively to the semiconductor wafer sales. Due to the low demand in January-February, the shipment value of the first quarter was 10.3 percent lower than in the corresponding period last year.
In January-March, technology sales consisted mainly of solar crystal sales.
Sales per market area
|
|
1.1.- |
1.1.- |
1.1.- |
1.1.- |
|
|
|
|
|
|
|
North America |
36% |
37% |
37% |
43% |
|
Europe |
26% |
31% |
30% |
25% |
|
Asia |
38% |
32% |
33% |
32% |
In the first quarter, the sales were strongest in Asia and North America. The relative proportion of Asia of the net sales grew during the period under review.
PROFITABILITY
January-March
In January-March, Okmetic's operating profit was 1.5 (2.8) million euro. The operating profit accounted for 8.1 (12.8) percent of net sales. Profit for the period amounted to 0.7 (2.7) million euro. Basic earnings per share was 0.04 (0.16) euro. Diluted earnings per share was 0.04 (0.16).
FINANCING
The company's financial situation is good. In January-March, net cash flow from operations amounted to -1.0 (-1.3) million euro. The cash flow from operations was weakened by 3.9 (6.0) million euro due to changes in working capital available to business operations.
On 31 March 2012, the company's liabilities amounted to 1.0 (1.0) million euro.
At the end of the period, cash and cash equivalents amounted to 7.2 (10.4) million euro. On 31 March 2012, the company's cash and cash equivalents exceeded the interest-bearing liabilities by 6.2 million euro (on 31 March 2011, cash and cash equivalents were 12.4 million euro higher than interest-bearing liabilities). The group has ensured the sufficiency of cash funds by increasing the committed credit facility of 3.0 million euro to 6.0 million euro. The credit facility was undrawn on 31 March 2012.
Return on equity amounted to 4.6 (18.3) percent. The company's equity ratio was 79.2 (78.9) percent. Equity per share was 3.69 (3.63) euro.
INVESTMENTS
In January-March, Okmetic's capital expenditure amounted to 2.6 (4.8) million euro.
The investments concerned mainly the board's decision in April 2011 to increase SOI wafer production capacity by extending the Vantaa plant. The around 30 million euro investment programme, to be implemented in 2011-2013, includes the plant extension and different kinds of production equipment. Building of the plant extension started in August 2011.
PRODUCT DEVELOPMENT
In January-March, the company expensed 0.5 (0.6) million euro in product development projects. Product development costs accounted for 2.8 (2.7) percent of net sales. The product development costs have not been capitalised. Product development has been allocated to SOI wafers and high and low resistivity wafers.
PERSONNEL
On average, Okmetic employed 351 (347) people in January-March. At the end of the period, 311 of the company's employees worked in Finland, 36 in the US, four in Japan, and one in Hong Kong.
OKMETIC'S CORPORATE GOVERNANCE
Okmetic Oyj's annual general meeting, which was held on 12 April 2012, adopted the annual accounts and the consolidated annual accounts for 2011 and discharged the company's management from liability. It was decided that a dividend of 0.28 euro per share would be distributed for 2011. The dividend was paid on Tuesday 24 April 2012. The annual general meeting decided also, in accordance with the proposal of the board of directors, to authorise the board of directors to decide upon its discretion on the payment of an additional dividend, should the company's financial situation permit this. The additional dividend, including all possible separate decisions on dividend payment, may amount up to a maximum of 0.40 euro per share and 15,000,000 euro in total. Moreover, the general meeting approved the proposal of the board of directors to authorise the board of directors to decide on the repurchase and/or the acceptance as pledge of the company's own shares as well as on the issuance of shares, the transfer of the company's own shares, and the issuance of special rights entitling to shares.
It was decided that there would be five members on the company's board of directors. Mr. Henri Österlund, Mr. Tapani Järvinen, Mr. Hannu Martola, and Ms. Mervi Paulasto-Kröckel were re-elected as members of the board of directors until the end of the next annual general meeting, and Mr. Mikko Puolakka was elected as a new member. The board of directors elected Henri Österlund as its chairman and Tapani Järvinen as its vice chairman in its organisation meeting held immediately after the annual general meeting.
Authorised Public Accountant PricewaterhouseCoopers Oy was elected as auditor, with APA Mikko Nieminen having the principal responsibility.
Authorisations given to the board of directors and other decisions of the annual general meeting have been notified in a stock exchange release published on 12 April 2012.
BUSINESS RISKS IN THE NEAR FUTURE
There have been no essential changes in the company's near future business risks and uncertainties. Okmetic's business operations are exposed to risks which may arise from the company's operations or changes in the business environment.
Okmetic's silicon wafer sales are targeted at the sensor and semiconductor producers in the electronics industry. The demand for semiconductor wafers is sensitive to economic fluctuations and changes in the market situation can be sudden and dramatic. The demand for sensor wafers is more stable. The proliferation of sensors in consumer electronics applications may, however, increase the susceptibility of this market too to economic fluctuations. Technology sales comprise mainly crystal sales, which is predominantly affected by the economic situation of the solar cell industry.
Okmetic's share of the global silicon wafer market is around one percent and the market prices have a notable effect on the price development of Okmetic's products. The company only has considerable pricing power with its own special products. The pricing of other wafers is mainly based on global market price.
Okmetic operates globally, and therefore the company's business operations are affected by risks due to currency fluctuations, consisting of the cash flows of purchases and sales. A significant part of sales are conducted in US dollars. The Japanese yen is another notable trading currency. Despite hedging, the company remains exposed to exchange rate fluctuations.
Substantial volumes of electricity are used in Okmetic's production. Despite hedging, the company is exposed to fluctuations in the price of electricity.
The company risks and uncertainty factors are dealt more profoundly in the company's annual report of 2011.
SHARES AND SHAREHOLDERS
On 31 March 2012, Okmetic Oyj's paid-up share capital, as entered in the Finnish Trade Register, was 11,821,250.00 euro. The number of shares was 17,287,500. The shares have no nominal value attached. Each share entitles its holder to one vote at general meetings. The company has one class of shares. The company's shares are included in the Finnish book-entry securities system.
SHARE PRICE DEVELOPMENT AND TRADING
A total of 1.1 (3.6) million shares were traded between 1 January and 31 March 2012, representing 6.6 (20.8) percent of the weighted average of share total of 17.3 (17.3) million during the period. The lowest quotation during the period was 4.98 (5.30) euro, and the highest 6.01 (6.65) euro, with the average being 5.63 (5.90) euro. The closing quotation for the period was 5.82 (6.55) euro. At the end of the period, the market capitalisation amounted to 100.6 (113.2) million euro.
OWN SHARES AND DIRECTED SHARE ISSUES
On 8 February 2012, Okmetic Oyj's board of directors announced of its decision to transfer a total of 56,033 own shares held by the company as a part of the company's share-based incentive scheme for the executive management group, of which the company has given a stock exchange release on 11 February 2010. All the shares were issued to the members of the executive management group in deviation from the shareholders' pre-emptive rights (directed share issue).
The rewards of the share reward programme were paid on one hand in Okmetic shares and on the other hand in a monetary amount covering taxes. The directed share issue without payment was executed in full as there was no consideration related to the issue.
At the end of the reporting period Okmetic held 241,543 own shares, which is approximately 1.4 percent of Okmetic's all shares and votes.
OTHER EVENTS IN THE INTERIM PERIOD
The company Kiinteistö Oy Piitalot which was part of Okmetic group has merged with Okmetic Oyj on 1 January 2012. Its assets and liabilities were transferred to Okmetic Oyj.
The Helsinki Court of Appeal gave a verdict in January in which it decided not to change the acquittal for President Kai Seikku rendered by the Helsinki District Court on 20 December 2010 and dismissed the prosecutor's claims on negligent abuse of insider information. The Helsinki Court of Appeal's verdict has entered into legal force as the prosecutor did not request for leave to appeal from the next instance. The charge was related to Seikku's actions while he was still working for his previous employer HKScan Oyj.
CONDENSED FINANCIAL STATEMENTS AND TABLES 1 JANUARY - 31 MARCH 2012 (unaudited)
ACCOUNTING POLICIES
These interim financial statements have been prepared in accordance with IAS 34, Interim Financial Reporting.
In preparing these interim financial statements, Okmetic has followed the same accounting policies as in the financial statements for 2011 except for the effect of changes required by the adoption of the following new or revised standards and interpretations as of 1 January 2012:
-IFRS 7 (amendment), Financial instruments: Disclosures - Derecognition.
-IAS 12 (amendment), Income Taxes - Deferred Tax.
The adoption of the aforementioned standards and interpretations has not had an effect on the figures presented from the reporting period.
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
|
1,000 euro |
1 Jan- |
1 Jan- |
1 Jan- |
|
|
|
|
|
|
Net sales |
18,902 |
22,055 |
83,186 |
|
Cost of sales |
-14,851 |
-15,939 |
-61,876 |
|
Gross profit |
4,051 |
6,116 |
21,310 |
|
Other income |
|
|
|
|
Operating |
|
|
|
|
Financial |
|
|
|
|
Profit before |
|
|
|
|
Income tax |
-517 |
428 |
-1,104 |
|
Profit for |
|
|
|
|
|
|
|
|
|
Other |
|
|
|
|
Cash flow |
|
|
|
|
Translation |
|
|
|
|
Other |
|
|
|
|
|
|
|
|
|
Total |
|
|
|
|
|
|
|
|
|
Profit for |
|
|
|
|
Equity holders |
|
|
|
|
|
|
|
|
|
Total |
|
|
|
|
Equity holders |
|
|
|
|
|
|
|
|
|
Basic earnings |
|
|
|
|
Diluted |
|
|
|
|
|
|
|
|
CONDENSED CONSOLIDATED BALANCE SHEET
|
1,000 euro |
31 Mar, |
31 Mar, |
31 Dec, |
|
|
|
|
|
|
Assets |
|
|
|
|
Non-current assets |
|
|
|
|
Intangible assets |
83 |
- |
- |
|
Property, plant and |
|
|
|
|
Other receivables |
3,696 |
4,251 |
3,255 |
|
Total non-current |
|
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
Inventories |
14,963 |
10,319 |
13,114 |
|
Receivables |
16,933 |
17,461 |
15,374 |
|
Financial assets at |
|
|
|
|
Cash and cash |
|
|
|
|
Total current assets |
39,049 |
41,158 |
39,745 |
|
|
|
|
|
|
Total assets |
78,675 |
77,475 |
77,887 |
|
|
|
|
|
|
Equity and liabilities |
|
|
|
|
Equity |
|
|
|
|
Equity attributable |
|
|
|
|
Share capital |
11,821 |
11,821 |
11,821 |
|
Other equity |
49,914 |
49,199 |
49,151 |
|
Total equity |
61,735 |
61,021 |
60,973 |
|
|
|
|
|
|
Liabilities |
|
|
|
|
Non-current |
|
|
|
|
Current liabilities |
13,669 |
14,927 |
13,946 |
|
Total liabilities |
16,940 |
16,454 |
16,914 |
|
|
|
|
|
|
Total equity and |
|
|
|
CONDENSED CONSOLIDATED CASH FLOW STATEMENT
|
1,000 euro |
1 Jan- |
1 Jan- |
1 Jan- |
|
|
|
|
|
|
Cash flows from operating |
|
|
|
|
Profit before tax |
1,229 |
2,296 |
11,339 |
|
Adjustments |
2,192 |
2,735 |
7,575 |
|
Change in working capital |
-3,878 |
-5,950 |
-6,782 |
|
Financial items |
11 |
-419 |
-401 |
|
Tax paid |
-520 |
- |
-39 |
|
Net cash from |
|
|
|
|
|
|
|
|
|
Cash flows from investing |
|
|
|
|
Purchases of property, |
|
|
|
|
Investments in fixed |
|
|
|
|
Net cash used in investing |
|
|
|
|
|
|
|
|
|
Cash flows from financing |
|
|
|
|
Repayments of long-term |
|
|
|
|
Payments of finance |
|
|
|
|
Share issue |
- |
- |
- |
|
Repurchase of own shares |
- |
- |
-1,147 |
|
Dividends paid |
-201 |
- |
-7,331 |
|
Net cash used in financing |
|
|
|
|
|
|
|
|
|
Increase (+) / |
|
|
|
|
Exchange rate changes |
-313 |
-434 |
304 |
|
Cash and cash |
|
|
|
|
Cash and cash |
|
|
|
|
|
|
|
|
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
|
|
Equity attributable to equity holders of parent company |
|||||
|
1,000 euro |
Share |
Share |
Reserve |
Other |
Retained |
Total |
|
Balance at |
|
|
|
|
|
|
|
Profit for |
|
|
|
|
|
|
|
Other com- |
|
|
|
|
|
|
|
Cash flow |
|
|
|
|
|
|
|
Translation |
|
|
|
|
|
|
|
Total com- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
|
|
|
|
|
|
|
Profit for |
|
|
|
|
|
|
|
Other com- |
|
|
|
|
|
|
|
Translation |
|
|
|
|
|
|
|
Total com- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
|
|
|
|
|
|
1)"Other reserves" contains hedge reserve and translation differences.
CHANGES IN PROPERTY, PLANT AND EQUIPMENT
|
1,000 euro
|
1 Jan- |
1 Jan- |
1 Jan- |
|
|
|
|
|
|
Carrying amount |
|
|
|
|
Additions |
2,592 |
4,837 |
11,992 |
|
Disposals |
- |
- |
- |
|
Depreciation |
1,512 |
-1,597 |
-6,252 |
|
Exchange differences |
-120 |
-245 |
78 |
|
Carrying amount |
|
|
|
COMMITMENTS AND CONTINGENCIES
|
1,000 euro |
31 Mar, |
31 Mar, |
31 Dec, |
|
|
|
|
|
|
Loans, secured with |
|
|
|
|
Collaterals |
8,073 |
8,073 |
8,073 |
|
Off-balance sheet |
|
|
|
|
|
|
|
|
|
Capital commitments |
6,199 |
4,226 |
5,424 |
|
|
|
|
|
|
Nominal values of |
|
|
|
|
Currency options, |
|
|
|
|
Currency options, |
|
|
|
|
Currency forward |
|
|
|
|
Electricity |
|
|
|
|
|
|
|
|
|
Fair values of |
|
|
|
|
Currency options, |
|
|
|
|
Currency options, |
|
|
|
|
Currency forward |
|
|
|
|
Electricity |
|
|
|
|
|
|
|
|
The contract price of the derivatives has been used as the nominal value of the underlying asset.
KEY FIGURES SHOWING FINANCIAL PERFORMANCE
|
1,000 euro |
1 Jan- |
1 Jan- |
1 Jan- |
|
|
|
|
|
|
Net sales |
18,902 |
22,055 |
83,186 |
|
Change in net sales |
|
|
|
|
Export and foreign |
|
|
|
|
Operating profit before |
|
|
|
|
% of net sales |
16.1 |
20.1 |
21.7 |
|
Operating profit |
1,535 |
2,828 |
11,817 |
|
% of net sales |
8.1 |
12.8 |
14.2 |
|
Profit before tax |
1,229 |
2,296 |
11,339 |
|
% of net sales |
6.5 |
10.4 |
13.6 |
|
Return on equity, % |
4.6 |
18.3 |
17.2 |
|
Return on investment, % |
7.9 |
15.1 |
18.7 |
|
Non-interest-bearing |
|
|
|
|
|
|
|
|
|
Net interest-bearing |
|
|
|
|
Net gearing ratio, % |
-9.8 |
-20.3 |
-16.8 |
|
Equity ratio, % |
79.2 |
78.9 |
78.9 |
|
Capital expenditure |
2,592 |
4,837 |
11,992 |
|
% of net sales |
13.7 |
21.9 |
14.4 |
|
Depreciation |
1,517 |
1,597 |
6,252 |
|
Research and development |
|
|
|
|
% of net sales |
2.8 |
2.7 |
2.9 |
|
|
|
|
|
|
Average number of |
|
|
|
|
Personnel at the |
|
|
|
KEY FIGURES PER SHARE
|
Euro |
31 Mar, |
31 Mar, |
31 Dec, |
|
|
|
|
|
|
Basic earnings |
|
|
|
|
Diluted earnings |
|
|
|
|
Equity per share |
3.69 |
3.63 |
3.68 |
|
Dividend per share |
- |
- |
0.28 |
|
Dividends/earnings, % |
- |
- |
45.8 |
|
Effective dividend |
|
|
|
|
Price/earnings(P/E) |
- |
- |
8.0 |
|
|
|
|
|
|
Share performance (1.1.-) |
|
|
|
|
Average trading price |
5.63 |
5.90 |
5.48 |
|
Lowest trading price |
4.98 |
5.30 |
3.50 |
|
Highest trading price |
6.01 |
6.65 |
6.65 |
|
Trading price at the |
|
|
|
|
Market capitalisation |
|
|
|
|
Trading volume (1 Jan-) |
|
|
|
|
Trading volume, |
|
|
|
|
In relation to weighted |
|
|
|
|
Trading volume, |
|
|
|
|
The weighted average |
|
|
|
|
The number of shares at |
|
|
|
When calculating earnings per share (EPS) and equity, Okmetic's own shares in its possession and Okmetic's shares owned by Okmetic Management Oy are deducted from the amount of shares.
QUARTERLY KEY FIGURES
|
1,000 euro |
10-12/ |
7-9/ |
4-6/ |
1-3/ |
|
|
|
|
|
|
|
Net sales |
|
|
|
18,902 |
|
Compared to previous |
|
|
|
|
|
Compared to corresponding |
|
|
|
|
|
Operating profit |
|
|
|
1,535 |
|
% of net sales |
|
|
|
8.1 |
|
Profit before tax |
|
|
|
1,229 |
|
% of net sales |
|
|
|
6.5 |
|
|
|
|
|
|
|
Net cash flow generated |
|
|
|
|
|
Investing activities |
|
|
|
-2,624 |
|
Financing activities |
|
|
|
-201 |
|
Increase/decrease in cash |
|
|
|
|
|
|
|
|
|
|
|
Personnel at the end |
|
|
|
|
|
1,000 euro |
10-12/ |
7-9/ |
4-6/ |
1-3/ |
|
|
|
|
|
|
|
Net sales |
18,134 |
21,250 |
21,747 |
22,055 |
|
Compared to previous |
|
|
|
|
|
Compared to corresponding |
|
|
|
|
|
Operating profit |
2,338 |
4,045 |
2,606 |
2,828 |
|
% of net sales |
12.9 |
19.0 |
12.0 |
12.8 |
|
Profit before tax |
2,439 |
4,117 |
2,487 |
2,296 |
|
% of net sales |
13.4 |
19.4 |
11.4 |
10.4 |
|
|
|
|
|
|
|
Net cash flow generated |
|
|
|
|
|
Investing activities |
-4,332 |
-1,100 |
1,035 |
-1,905 |
|
Financing activities |
-2,771 |
-664 |
-5,043 |
- |
|
Increase/decrease in cash |
|
|
|
|
|
|
|
|
|
|
|
Personnel at the end |
|
|
|
|
MAJOR SHAREHOLDERS ON 31 MARCH 2012
|
Shares, |
Share, |
|
|
Ilmarinen Mutual Pension |
|
|
|
Mandatum Life Insurance |
|
|
|
The State Pension Fund |
600,000 |
3.5 |
|
Varma Mutual Pension |
|
|
|
Veritas Pension |
|
|
|
Okmetic Management oy |
400,000 |
2.3 |
|
Etra-Invest Oy Ab |
400,000 |
2.3 |
|
Nordea Nordic Small |
|
|
|
Okmetic Oyj |
241,543 |
1.4 |
|
Sijoitusrahasto Taaleritehdas |
|
|
|
Kaleva Mutual Insurance |
|
|
|
Aktia Secura Fund |
201,182 |
1.2 |
|
Oy Ingman Finance Ab |
200,051 |
1.2 |
|
Sijoitusrahasto Aktia Capital |
140,387 |
0.8 |
|
EQ Pikkujättiläiset / |
|
|
|
Kiilholma Antti Tapio |
92,248 |
0.5 |
|
Stenhäll Turo |
75,000 |
0.4 |
|
Virtanen Yhtiöt Oy |
70,000 |
0.4 |
|
Sr Eq Technology |
60,000 |
0.4 |
|
Sr Arvo Finland Value |
56,611 |
0.3 |
|
Foreign investors and |
|
|
|
Others |
7,241,611 |
41.9 |
|
Total |
17,287,500 |
100.0 |
DEFINITIONS OF KEY FINANCIAL FIGURES
|
|
|
|
|
Operating profit before depreciation (EBITDA) |
= |
Operating profit + depreciation |
|
|
|
|
|
Return on equity (ROE), % |
= |
Profit/loss for the period x 100/ |
|
|
|
Equity(Average for the period) |
|
|
|
|
|
Return on investment (ROI), % |
= |
(Profit/loss before tax + interest and other financial expenses) x 100/ |
|
|
|
Balance sheet total - non-interest bearing liabilities(average for the period) |
|
|
|
|
|
Equity ratio, % |
= |
Equity x 100/ |
|
|
|
Balance sheet total - advances received |
|
|
|
|
|
Net interest-bearing liabilities |
= |
Interest-bearing liabilities - cash and cash equivalents |
|
|
|
|
|
Net gearing ratio, % |
= |
(Interest-bearing liabilities - cash and cash equivalents) x 100/ |
|
|
|
Equity |
|
|
|
|
|
Earnings per share |
= |
Profit/loss for the period attributable to equity holders of the parent company/ |
|
|
|
Adjusted weighted average number of shares in issue during the period |
|
|
|
|
|
Equity per share |
= |
Equity attributable to equity holders of the parent company/ |
|
|
|
Adjusted number of shares at the end of the period |
|
|
|
|
|
Dividend per share |
= |
Dividend for the period/ |
|
|
|
Adjusted number of shares at the end of the period |
|
|
|
|
|
Effective dividend yield, % |
= |
Dividend per share x 100/ |
|
|
|
Trading price at the end of the period |
|
|
|
|
|
Price/earnings ratio (P/E) |
= |
Last adjusted trading price at the end of the period/ |
|
|
|
Earnings per share |
|
|
|
|
|
Average trading price |
= |
Total traded amount in euro/ |
|
|
|
Adjusted number of shares traded during the period |
|
|
|
|
|
Market capitalisation at the end of the period |
= |
Number of shares at the end of the period x trading price at the end of the period |
|
|
|
|
|
Trading volume |
= |
Number of shares traded during the period/ |
|
|
|
Weighted average number of shares during the period |
All figures of the financial tables are rounded, and consequently the sum of individual figures can deviate from the presented sum figure.
The future estimates and forecasts in this interim report are based on company management's current knowledge. Actual events and results may differ from the estimates presented here.
PRESS CONFERENCE
A press conference for the media and analysts will be held on Friday, 27 April 2012 at 1.00 p.m. at Helsinki World Trade Center, Aleksanterinkatu 17, second floor, Helsinki. In the conference, Okmetic's President Kai Seikku will present the group's development in January-March 2012 and prospects for 2012.
We ask participants to kindly give advance notice of their attendance by email to [email protected] or by telephone to +358 9 5028 0406/Marika Mäntymaa.
OKMETIC OYJ
Board of directors
For further information, please contact:
President Kai Seikku, Okmetic Oyj,
tel. +358 400 200 288, email: [email protected]
Senior Vice President, Finance, IT, and Communications
Juha Jaatinen, Okmetic Oyj, tel. +358 9 5028 0286,
email: [email protected]
Distribution:
NASDAQ OMX Helsinki
Principal media
www.okmetic.com
OKMETIC IN BRIEF
Take it higher
Okmetic is a technology company which supplies tailor-made silicon wafers for sensor and semiconductor industries and sells its technological expertise to the solar cell industry. Okmetic provides its customers with solutions that boost their competitiveness and profitability.
Okmetic's silicon wafers are part of a further processing chain that produces end products that improve human interaction and quality of life. Okmetic's products are based on high-tech expertise that generates added value for customers, innovative product development and an extremely efficient production process.
Okmetic has a global customer base and sales network, production plants in Finland and the US and contract manufacturers in Japan and China. Okmetic's shares are listed on NASDAQ OMX Helsinki under the code OKM1V. For more information on the company, please visit our website at www.okmetic.com.
Copyright Thomson Reuters
Attachment(s)
http://hugin.info/132025/R/1606466/509274.pdf
Regulatory News
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: %s via Thomson Reuters ONE
[HUG#1606466]
Ufficio Stampa
Thomson Reuters (Leggi tutti i comunicati)
3 Times Square
10036 New York, NY
